Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up UPDATE

Mon, 29th Apr 2013 08:17

Afren: Liberum Capital shifts target price from 130p to 136p and maintains a hold recommendation.AngloAmerican: Nomura upgrades from reduce to neutral with a target price of 1700p.Antofagasta: Nomura cuts target price from 1250p to 1200p, while its neutral rating remains unchanged. Investec reduces target price from 934p to 892, while upgrading from sell to reduce.AstraZeneca: Morgan Stanley takes target price from 3310p to 3400p and reiterates an equal-weight rating.Auhua Clean Energy: HB Markets initiates with a buy recommendation.Barratt Developments: Jefferies restarts with a target price of 385p (prev.: 250p) and a buy recommendation.Bellway: Jefferies moves target price from 1100p to 1668p and upgrades to buy.Berkeley Group: Jefferies increases target price from 1500p to 2005p upgrading to hold.Bovis Homes Group: Jefferies ups target price from 670p to 897p and retains its buy recommendation.BT Group: Liberum Capital revises target price from 300p to 315p ans stays with its buy recommendation.Cambria Automobiles: Canaccord Genuity shifts target price from 35p to 39p keeping its buy recommendation.Countrywide: Credit Suisse initiates with a target price of 510p and an outperform rating.Croda International: UBS reduces target price from 2550p to 2420p leaving its sell recommendation unchanged.Derwent London: Espirito Santo increases target price from 2009p to 2422p and stays with a neutral rating.Elementis: Numis ups target price from 247p to 255p and keeps a hold recommendation.Eurasian Natural Resources: Nomura upgrades from reduces to neutral with a target price of 300p.Fenner: Jefferies reduces target price from 490p to 470p reiterating a buy recommendation.Galliford Try: Jefferies takes target price from 920p to 1176p and maintains its buy recommendation.Great Portland Estates: Espirito Santo ups target price from 472p to 507p keeping a neutral rating.Greene King: Panmure Gordon raises target price from 607p to 686p keeping a hold recommendation.Greggs: Panmure Gordon reduces target price from 550p to 450p and retains a buy recommendation. Liberum Capital cuts target price from 418p to 406p leaving its sell recommendation unchanged. Canaccord Genuity moves target price from 485p to 380p and downgrades to sell.Innovation Group: Panmure Gordon shifts target price from 36p to 38p and maintains a buy recommendation.Kazakhmys: Nomura lowers target price from 475p to 450p retaining a reduces rating.Legal & General: Panmure Gordon ups target price from 190p to 205p and stays with its buy recommendation.Orosur Mining: Canaccord Genuity lowers target price from 50p to 42p, while leaving its buy recommendation unaltered.Persimmon: Jefferies restarts with a target price of 1162p (prev.: 850p) and a buy recommendation.Provident Financial: Citigroup raises target price from 1410p to 1660p maintaining its neutral rating.Reed Elsevier: Citigroup takes target price from 750p to 780p, while downgrading to neutral.Redefine International: Investec shifts target price from 38p to 40p and keeps a buy recommendation.Redrow: Jefferies ups target price from 200p to 278p reiterating a hold recommendation.Restaurant Group: Nomura revises target price from 425p to 515p and leaves its buy recommendation unchanged.Rotala: Numis moves target price from 49p to 54p and upgrades to buy.Sainsbury: Citigroup downgrades to neutral with a target price of 385p.Shaft Sinkers Holding: Westhouse Securities restarts with a target price of 52p and a buy recommendation.Shanks Group: Westhouse Securities shifts target price from 113p to 108p, while staying with its buy recommendation.Taylor Wimpey: Jefferies increases target price from 85p to 111p and maintains its buy recommendation.UBM: Citigroup raises target price from 749p to 800p upgrading to buy.Ukrproduct Group: Cantor Fitzgerald ups target price from 11p to 20p and upgrades to buy.WPP Group: Morgan Stanley increases target price from 1090p to 1135p and keeps an equal-weight rating.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.